4th Quarter - Report
PODESTA GROUP, INC. for VIROPHARMA INCORPORATED
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA regulation of antibiotics, plasma derivatives, and rare diseases. Insurance and Medicaid coverage of rare disease therapies and essential health benefits. Orphan drug tax. Drug supply chain security.Sustainable Growth Rate repeal and reform proposals. Patient-Centered Outcome Research Institute (PCORI). Rare disease panels.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NORA CONNORS | — |
| STEPHEN NORTHRUP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.